Homocysteine thiolactone and H2O2 induce amino acid modifications and alter the fibrillation propensity of the Aβ25–35 peptide
暂无分享,去创建一个
[1] Bryan M. Delfing,et al. Met35 Oxidation Hinders Aβ25-35 Peptide Aggregation within the Dimyristoylphosphatidylcholine Bilayer. , 2021, ACS chemical neuroscience.
[2] S. Dasgupta,et al. Gallic acid induced dose dependent inhibition of lysozyme fibrillation. , 2017, International journal of biological macromolecules.
[3] J. Carver,et al. Measurement of amyloid formation by turbidity assay—seeing through the cloud , 2016, Biophysical Reviews.
[4] S. Dasgupta,et al. Hydropathy: the controlling factor behind the inhibition of Aβ fibrillation by graphene oxide , 2016 .
[5] S. Dasgupta,et al. Hydrophobic tail length plays a pivotal role in amyloid beta (25–35) fibril–surfactant interactions , 2016, Proteins.
[6] Ann Tiiman,et al. Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide , 2015, Biochemistry and biophysics reports.
[7] G. S. Sharma,et al. N-Homocysteinylation Induces Different Structural and Functional Consequences on Acidic and Basic Proteins , 2014, PloS one.
[8] A. Moosavi-Movahedi,et al. Effect of homocysteinylation on structure, chaperone activity and fibrillation propensity of lens alpha-crystallin. , 2013, Protein and peptide letters.
[9] S. Hornemann,et al. Multiple Substitutions of Methionine 129 in Human Prion Protein Reveal Its Importance in the Amyloid Fibrillation Pathway* , 2012, The Journal of Biological Chemistry.
[10] A. Moosavi-Movahedi,et al. Effect of Homocysteine Thiolactone on Structure and Aggregation Propensity of Bovine Pancreatic Insulin , 2011, The protein journal.
[11] A. Oliveira‐Brett,et al. Boron doped diamond and glassy carbon electrodes comparative study of the oxidation behaviour of cysteine and methionine. , 2011, Bioelectrochemistry.
[12] D. Butterfield,et al. Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories , 2011, NeuroMolecular Medicine.
[13] F. Sbrana,et al. Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. , 2010, Journal of molecular biology.
[14] V. Andrisano,et al. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity. , 2008, Journal of medicinal chemistry.
[15] D. Jacobsen,et al. Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. , 2007, Antioxidants & redox signaling.
[16] H. Jakubowski,et al. Modification by homocysteine thiolactone affects redox status of cytochrome C. , 2007, Biochemistry.
[17] H. Jakubowski. Pathophysiological consequences of homocysteine excess. , 2006, The Journal of nutrition.
[18] M. Warren,et al. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. , 2006, Biochemistry.
[19] Knut Engedal,et al. Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study , 2005, Annals of neurology.
[20] C. Schöneich. Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. , 2005, Biochimica et biophysica acta.
[21] J. Kelly,et al. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. , 2003, Biochemistry.
[22] S. Dante,et al. Beta-amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extents. , 2002, Biophysical journal.
[23] I. Kang,et al. Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Aβ-(1–42) Peptide of Alzheimer's Disease* , 2002, The Journal of Biological Chemistry.
[24] C. Riener,et al. Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4′-dithiodipyridine , 2002, Analytical and bioanalytical chemistry.
[25] Magnus Palmblad,et al. Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers* , 2002, The Journal of Biological Chemistry.
[26] V. Sánchez-Margalet,et al. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. , 2001, Journal of molecular endocrinology.
[27] M. Staufenbiel,et al. Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.
[28] D. Butterfield,et al. Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.
[29] J. Sipe,et al. Review: history of the amyloid fibril. , 2000, Journal of structural biology.
[30] H. Jakubowski. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] W. Markesbery,et al. Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain , 1999, Journal of neurochemistry.
[32] D. Butterfield,et al. Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress , 1999, Brain Research Bulletin.
[33] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[34] G. Hankey,et al. Homocysteine and vascular disease , 1999, The Lancet.
[35] Xudong Huang,et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.
[36] D. Craik,et al. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? , 1998, Biochemistry.
[37] H. Jakubowski. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. , 1997, The Journal of biological chemistry.
[38] K. Imahori,et al. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution. , 1995, Journal of biochemistry.
[39] J. Valk,et al. Hyperhomocysteinaemia; with reference to its neuroradiological aspects , 1995, Neuroradiology.
[40] C. Cotman,et al. Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .
[41] T. Holzman,et al. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. , 1994, Biophysical journal.
[42] R. Martins,et al. Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress , 1986, Journal of neurochemistry.
[43] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[44] K. Bailey,et al. The X-ray interpretation of denaturation and the structure of the seed globulins. , 1935, The Biochemical journal.
[45] A. Rego,et al. Protective effect of zinc on amyloid-ß 25–35 and 1–40 mediated toxicity , 2009, Neurotoxicity Research.
[46] E. Porcellini,et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. , 2005, The American journal of clinical nutrition.
[47] C. J. McGrath,et al. Effect of exchange rate return on volatility spill-over across trading regions , 2012 .
[48] W. Vogt. Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.